Search

Your search keyword '"Hyllner J"' showing total 74 results

Search Constraints

Start Over You searched for: Author "Hyllner J" Remove constraint Author: "Hyllner J"
74 results on '"Hyllner J"'

Search Results

1. Stem Cells

5. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage

6. P1 Induction of regeneration of articular cartilage defects by freeze dried particulate cartilage allografts

8. Human Embryonic Mesodermal Progenitors Highly Resemble Human Mesenchymal Stem Cells and Display High Potential for Tissue Engineering Applications

9. Regulation of 'stemness' and stem cell differentiation by microRNAs

12. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture

14. P-1014

15. Human Progenitor Cells for Bone Engineering Applications

17. Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors.

18. Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015.

19. Cell-based therapy technology classifications and translational challenges.

21. Setting Up a Haplobank: Issues and Solutions.

22. Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives.

23. On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip.

24. Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source.

25. Transplantation of human embryonic stem cells onto a partially wounded human cornea in vitro.

26. Labeled stem cells as disease models and in drug discovery.

27. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

28. Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed bed/column bioreactor.

29. Free-form-fabricated commercially pure Ti and Ti6Al4V porous scaffolds support the growth of human embryonic stem cell-derived mesodermal progenitors.

30. Principles for derivation of human embryonic stem cells.

31. Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells.

32. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells.

33. Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells.

34. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective.

35. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control.

36. Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage.

37. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications.

38. The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking.

39. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.

40. Single cell enzymatic dissociation of human embryonic stem cells: a straightforward, robust, and standardized culture method.

41. Coculture of human embryonic stem cells and human articular chondrocytes results in significantly altered phenotype and improved chondrogenic differentiation.

42. Regulation of 'stemness' and stem cell differentiation by microRNAs.

43. Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine.

44. Human embryonic stem cell technologies and drug discovery.

45. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.

46. Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells.

47. Creation of engineered human embryonic stem cell lines using phiC31 integrase.

48. Human embryonic stem cells: current technologies and emerging industrial applications.

49. Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces.

50. The application of human embryonic stem cell technologies to drug discovery.

Catalog

Books, media, physical & digital resources